HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition by lymph node cells and promotion by fetal hepatocytes of murine tumours without or with chemotherapy.

Abstract
The growth of a syngeneic Moloney lymphoma in CBA mice was inhibited by the injection of lymph node cells from normal CBA donors. This cytotherapeutic effect was also seen after chemotherapy with cyclophosphamide (CY) or dimethylmyleran (DMM). Two other murine tumours, the Meth A sarcoma in Balb/c mice and the L1210 leukemia in BDF1 mice, did not respond to treatment with normal syngeneic cells. In the L1210 system, tumour-promoting effects of fetal liver cells were demonstrated. The tumour inhibitory effects of normal lymph node cells against the Moloney lymphoma may be a virus-dependent phenomenon mediated through interferon and natural killer' cells. The experiments also showed the sensitivity of the Moloney lymphoma and the Meth A sarcoma to CY and DMM and the responsiveness of the L1210 leukemia to AAFC.
AuthorsG L Floersheim, J Torhorst
JournalOncology (Oncology) Vol. 38 Issue 6 Pg. 321-8 ( 1981) ISSN: 0030-2414 [Print] Switzerland
PMID6170919 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Carcinogens
  • dimethylmyleran
  • 5-fluoro-2,2'-cyclocytidine
  • Cyclophosphamide
  • Ancitabine
  • Busulfan
Topics
  • Ancitabine (analogs & derivatives, therapeutic use)
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Busulfan (analogs & derivatives, therapeutic use)
  • Carcinogens
  • Cyclophosphamide (therapeutic use)
  • Female
  • Killer Cells, Natural (immunology)
  • Leukemia, Experimental (immunology)
  • Liver (embryology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred CBA
  • Moloney murine leukemia virus
  • Neoplasms, Experimental (immunology)
  • Sarcoma, Experimental (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: